0001437749-17-012084.txt : 20170630
0001437749-17-012084.hdr.sgml : 20170630
20170630160225
ACCESSION NUMBER: 0001437749-17-012084
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170510
FILED AS OF DATE: 20170630
DATE AS OF CHANGE: 20170630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Diffusion Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001053691
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300645032
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: (434) 220-0718
MAIL ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
FORMER COMPANY:
FORMER CONFORMED NAME: RestorGenex Corp
DATE OF NAME CHANGE: 20140307
FORMER COMPANY:
FORMER CONFORMED NAME: Stratus Media Group, Inc
DATE OF NAME CHANGE: 20080722
FORMER COMPANY:
FORMER CONFORMED NAME: FERIS INTERNATIONAL, INC.
DATE OF NAME CHANGE: 20080228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gainer John
CENTRAL INDEX KEY: 0001662697
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37942
FILM NUMBER: 17942062
MAIL ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
4/A
1
rdgdoc.xml
FORM 4/A
X0306
4/A
2017-05-10
2017-05-12
0001053691
Diffusion Pharmaceuticals Inc.
DFFN
0001662697
Gainer John
2020 AVON COURT, SUITE 4
CHARLOTTESVILLE
VA
22902
1
1
Chief Scientific Officer
Stock Option (Right to Buy)
2.96
2017-05-10
4
A
0
34000
0
A
2027-05-10
Common Stock
34000
34000
D
The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on May 31, 2020.
This amendment is being filed solely to correct an error in the reported exercise price of the Derivative Security in the original filing.
/s/ Ben L. Shealy, attorney-in-fact for John L. Gainer
2017-06-30